The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

Peritoneal dialysis (PD) is a treatment modality for end-stage renal disease (ESRD) patients. Dextrose is a common osmotic agent used in PD solutions and its absorption may exacerbate diabetes mellitus, a common complication of ESRD. PD solutions also contain glucose degradation products (GDPs) that...

Full description

Bibliographic Details
Main Authors: Chia-Ning Chang, Chih-Yuan Niu, Ann Charis Tan, Chia-Hao Chan, Chun-Fan Chen, Tz-Heng Chen, Szu-Yuan Li, Yung-Tai Chen, Fan-Yu Chen, Wen-Sheng Liu, Chih-Ching Lin, Guor-Jien Wei
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
glucose degradation products
peritoneal dialysis
far-infrared therapy
diabetes mellitus
Online Access:https://www.mdpi.com/1422-0067/22/7/3732

Internet

https://www.mdpi.com/1422-0067/22/7/3732

Similar Items